Search Results

search
Enzyme Replacement Therapy Market
Enzyme Replacement Therapy Market Trends, Developments and Strategies 2025-2030: A Projected $15.44 Billion Landscape
February 07, 2025 06:19 ET | Research and Markets
Dublin, Feb. 07, 2025 (GLOBE NEWSWIRE) -- The "Enzyme Replacement Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
Protease Market
Rising Nutraceutical Needs Propel Protease Market, Projected Steady Expansion Through 2030 - Protease Market Set for Strong 5.9% Annual Growth
January 27, 2025 04:08 ET | Research and Markets
Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "Protease Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering.The protease market is expected to grow at a...
Global Enzyme Replacement Therapy Market
Global Enzyme Replacement Therapy (ERT) Market Research Report 2023: A $14.79 Million Market in 2027 at a CAGR of 8.1% - Long-term Forecast to 2032
October 02, 2023 05:14 ET | Research and Markets
Dublin, Oct. 02, 2023 (GLOBE NEWSWIRE) -- The "Enzyme Replacement Therapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global enzyme replacement therapy...
ARC logo.png
Enzyme Replacement Therapy Market Set to Accelerate at a CAGR of 7.6%, Projected to Ascend to a Value of USD 20.6 Billion by 2032
June 27, 2023 09:38 ET | Acumen Research and Consulting
NEWYORK, June 27, 2023 (GLOBE NEWSWIRE) -- The Global Enzyme Replacement Therapy Market Size accounted for USD 10.1 Billion in 2022 and is projected to achieve a market size of USD 20.6 Billion by...
Amicus-logo.jpg
Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the European Union
June 27, 2023 07:00 ET | Amicus Therapeutics, Inc.
PHILADELPHIA, June 27, 2023 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for...
First-Wave-Logo-FINAL-RGB[1].jpg
First Wave BioPharma Announces First Patient Dosed in Phase 2 SPAN Clinical Trial of Enhanced Adrulipase Formulation
March 09, 2023 07:00 ET | First Wave BioPharma, Inc.
BOCA RATON, Fla., March 09, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Growth Plus Reports Logo.jpg
Enzyme Replacement Therapy Market Size to Hit USD US$ 21.25 billion by 2030 | Growth Plus Reports
February 09, 2023 07:00 ET | Growth Plus Reports
Newark, New Castle, USA, Feb. 09, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Enzyme Replacement Therapy Market is expected to clock US$...
FBI LOGO TM.png
With 8.8% CAGR, Enzyme Replacement Therapy Market Size worth USD 20.58 Billion in 2028
October 12, 2022 05:34 ET | Fortune Business Insights
Pune, India, Oct. 12, 2022 (GLOBE NEWSWIRE) -- The global enzyme replacement therapy market size is predicted to reach USD 20.58 billion by 2028 at a CAGR of 8.8% during the forecast period. Fortune...
GMILogo_Vertical-Gradient.png
Fabry Disease Treatment Market to surpass USD 3.5 billion by 2030, says Global Market Insights Inc.
September 26, 2022 06:33 ET | Global Market Insights Inc.
Selbyville, Delaware, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Fabry disease treatment market value is projected to cross USD 3.5 billion by 2030 , according to a new research report by Global Market...
Persistence Market Research
Intracranial Therapeutic Delivery Market revenue will climb to US$ 4.2 Bn by the end of 2032 – Persistence Market Research
August 08, 2022 10:00 ET | Persistence Market Research
New York, Aug. 08, 2022 (GLOBE NEWSWIRE) -- The global intracranial therapeutic delivery market is currently valued at around US$ 1.6 Bn and is anticipated to progress at an impressive CAGR of 7.9%...